|
Name |
(2R,3S,4aS,7R,8R,8aS)-2,3,4'-trihydroxy-4,4,7,8a-tetramethylspiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2'-7,8-dihydro-3H-furo[2,3-e]isoindole]-6'-one
|
Molecular Formula | C23H31NO5 | |
IUPAC Name* |
(2R,3S,4aS,7R,8R,8aS)-2,3,4'-trihydroxy-4,4,7,8a-tetramethylspiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2'-7,8-dihydro-3H-furo[2,3-e]isoindole]-6'-one
|
|
SMILES |
C[C@@H]1CC[C@@H]2[C@@]([C@@]13CC4=C(C=C5C(=C4O3)CNC5=O)O)(C[C@H]([C@H](C2(C)C)O)O)C
|
|
InChI |
InChI=1S/C23H31NO5/c1-11-5-6-17-21(2,3)19(27)16(26)9-22(17,4)23(11)8-13-15(25)7-12-14(18(13)29-23)10-24-20(12)28/h7,11,16-17,19,25-27H,5-6,8-10H2,1-4H3,(H,24,28)/t11-,16-,17+,19-,22+,23-/m1/s1
|
|
InChIKey |
RUBLIKRGQGISNL-DXORJMCXSA-N
|
|
Synonyms |
(2R,3S,4aS,7R,8R,8aS)-2,3,4'-trihydroxy-4,4,7,8a-tetramethylspiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2'-7,8-dihydro-3H-furo[2,3-e]isoindole]-6'-one; 159096-43-2; NCGC00347551-02_C23H31NO5_(2R,2'R,4a'S,6'S,7'R,8a'S)-4,6',7'-Trihydroxy-2',5',5',8a'-tetramethyl-3',4',4a',5',6',7,7',8,8',8a'-decahydro-2'H-spiro[furo[2,3-e]isoindole-2,1'-naphthalen]-6(3H)-one; CHEMBL3104974; DTXSID101346959; ZINC3809583; F1839-A; NCGC00347551-02
|
|
CAS | 159096-43-2 | |
PubChem CID | 10069635 | |
ChEMBL ID | CHEMBL3104974 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 401.5 | ALogp: | 2.8 |
HBD: | 4 | HBA: | 5 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 99.0 | Aromatic Rings: | 5 |
Heavy Atoms: | 29 | QED Weighted: | 0.535 |
Caco-2 Permeability: | -5.113 | MDCK Permeability: | 0.00000580 |
Pgp-inhibitor: | 0.015 | Pgp-substrate: | 0.985 |
Human Intestinal Absorption (HIA): | 0.035 | 20% Bioavailability (F20%): | 0.656 |
30% Bioavailability (F30%): | 0.033 |
Blood-Brain-Barrier Penetration (BBB): | 0.259 | Plasma Protein Binding (PPB): | 93.29% |
Volume Distribution (VD): | 0.743 | Fu: | 12.84% |
CYP1A2-inhibitor: | 0.186 | CYP1A2-substrate: | 0.613 |
CYP2C19-inhibitor: | 0.03 | CYP2C19-substrate: | 0.327 |
CYP2C9-inhibitor: | 0.405 | CYP2C9-substrate: | 0.767 |
CYP2D6-inhibitor: | 0.519 | CYP2D6-substrate: | 0.311 |
CYP3A4-inhibitor: | 0.135 | CYP3A4-substrate: | 0.197 |
Clearance (CL): | 11.782 | Half-life (T1/2): | 0.524 |
hERG Blockers: | 0.057 | Human Hepatotoxicity (H-HT): | 0.296 |
Drug-inuced Liver Injury (DILI): | 0.134 | AMES Toxicity: | 0.01 |
Rat Oral Acute Toxicity: | 0.971 | Maximum Recommended Daily Dose: | 0.956 |
Skin Sensitization: | 0.927 | Carcinogencity: | 0.108 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.161 |
Respiratory Toxicity: | 0.939 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003009 | 1.000 | D0D2TN | 0.267 | ||||
ENC003012 | 0.816 | D0D1SG | 0.261 | ||||
ENC003259 | 0.785 | D0KR5B | 0.261 | ||||
ENC005396 | 0.773 | D08PIQ | 0.256 | ||||
ENC001965 | 0.729 | D0L2LS | 0.252 | ||||
ENC003014 | 0.691 | D02JNM | 0.248 | ||||
ENC002994 | 0.677 | D04SFH | 0.246 | ||||
ENC002995 | 0.625 | D04VIS | 0.246 | ||||
ENC003789 | 0.625 | D0Y2YP | 0.244 | ||||
ENC003552 | 0.596 | D0Z1FX | 0.243 |